INTRODUCTION
Although it is extensively used to control light and moderate pain in humans, the use of tramadol in veterinary patients is relatively recent (NATALINI & ROBINSON, 2000) . In horses, tramadol is quickly metabolized mainly into N-desmethyltramadol (M2), which is pharmacologically inactive, and its clinical effi ciency is unclear in this species as compared to humans (GIORGI et al., 2007) . It is believed that the analgesic effects of tramadol can be associated with other mechanisms of action, such as the modulation of the serotoninergic and monoaminergic pathways (NATALINI& ROBINSON, 2000; DHANJAL et al., 2009; KNYCH et al., 2013) .
The route of administration of the tramadol in horses and the model of nociceptive stimulation seem to infl uence the observed analgesic effects. When a 2mg kg -1 dose was administered by epidural injection, with no nociceptive evaluation, the drug produced plasma concentrations >100ng mL -1
; if it was extrapolated to human beings, such concentrations would be enough to achieve signifi cant analgesia (GIORGI et al., 2010) . Recently, KNYCH et al. (2013) observed plasma tramadol concentrations greater than those necessary for analgesia in human patients for doses of 0.5 to 3.0mg kg -1 in horses. NATALINI & ROBINSON (2000) , when evaluating the analgesic effects of tramadol after the administration of 1mg kg -1 by epidural injection, observed the presence of a signifi cant analgesia to electrical stimulation comparable to that provided by morphine. As for intravenous injection, a original study that used a 2mg kg -1 dose of tramadol did not reveal analgesic effects in healthy horses subjected to thermal stimulation (DHANJAL et al., 2009) .
Pressure algometry, through mechanical stimulation, is repeatable and provides quantitative information on nociception (HAUSSLER & ERB, 2006) . One method, von Frey fi laments, described by Maximilian von Frey in 1896, has been used with relative safety and repeatability for the evaluation of cutaneous sensitivity in horses (REDUA et al., 2002; OLESKOVICZ et al., 2006) and dogs (DUQUE et al., 2004 , KUKANICH & PAPICH, 2011 . As an alternative to the von Frey fi laments, electronic methods have been developed and tested on other species (CUNHA et al., 2004; DENADAI-SOUZA et al., 2009) and showed advantages over the classic method, including a reduction in the number of attempts required to evaluate the nociceptive threshold, the elimination of problems in the standardization of the fi laments.
The objectives of this study were to evaluate the clinical and cardiorespiratory effects and the antinociceptive mechanic potential of three different doses of tramadol administered intravenously in horses. It was hypothesized that tramadol would have antinoceptive effects in horses undergoing mechanical stimulation.
MATERIAL AND METHODS
The experiment was conducted after its approval by the institutional animal care and use committee.Seven healthy mixed-breed adult horses of either sex, aged 9-13 years old and weighing 318±36kg, were used in the study. The horses were deemed to be healthy on the basis of physical examination and standard laboratory tests.
The horses were acclimated by daily restraint in the stocks, for 15 days before the beginning of the experiment. The sequence of treatments for each animal was randomly determined taking care that each animal was not allocated to the same treatment more than once. The evaluators were blinded to the sequence of treatments until the end of the experiment.Each horse was studied on three occasions using a randomized crossover design, with a minimum of 15 days between experiments.
Tramadol hydrochloride 5% a was prepared with a fi nal concentration of 10mg mL -1 of tramadol in saline solution and infused over 10 minutes from a syringe pump b . The horses were distributed into three treatments named Tr1, Tr2 and Tr3 to receive 1, 2, and 3mg kg -1 doses of tramadol IV, respectively. The evaluations were performed immediately before the IV injection and 5, 10, 20, 40, 60, 90, 120 , and 180 minutes after the application of tramadol (T0, T5, T10, T20, T40, T60, T90, T120, T180, respectively).
A computer was used to record and analyze the electrocardiogram (ECG) c . An oscillometric monitor d was attached to a cuff on the tail of the horse to measure arterial blood pressure. The width of the cuff was 25-30% of the tail circumference.
The anterior region of the coronary band of the left forelimb was prepared for assessment of the nociceptive threshold. This was evaluated using a digital analgesiometer based on the von Frey method e .The equipment consists of a pressure transducer adapted with a cable to a digital counter with 0.1g precision which records the weight (grams force, gf) applied. This device includes a transducer arm with a force measurement capacity of 0.1 to 1000gf (0.98mN to 9.81N). Mechanical threshold were made by the same operator, who blinded to the actual readings obtained.
For the basal values, it was calculated the arithmetic mean of three measurements performed at 10-minute intervals. It was measured heart rate from the ECG (HR -beats minute -1 ); and respiratory rate (f R -breaths minute -1 ) by counting the chest movements over 1 minute. The systolic arterial pressure (SAP), diastolic arterial pressure (DAP) and mean arterial pressure (MAP) were obtained from the noninvasive oscillometric device.
The degree of sedation was determined by measuring head position (HP), considering the distanceof nostrils in relation to the ground with a ruler fi xed to the stock.The baseline value of the head position was measured in triplicate at 10-minute intervals, a result of the arithmetic mean of the measurements. The operator recorded the measure at a minimal distance of 3 meters from the animal using a measuring tape tied to the stock, aiming not to provoke any stimulus. As the animals were conditioned to the management, a few minutes after being restrained in the stock they seemed calm without abrupt movements with the head. If there were discrepant values due to some unexpected reaction of the animal, new measurements were taken. The results were converted to percentages to avoid the variability caused by the size differences between the horses (RINGER et al., 2012) .
Gastrointestinal motility (GI) was evaluated by auscultation using a modifi cation of the method described by SINGH et al. (1997) . Four abdominal quadrants (upper and lower on the left and right sides) were ausculted for at least 30 seconds (60 seconds in the case of low frequency) at two sites per quadrant by one person who was not aware of the treatment administered to each horse.
The mechanical nociceptive threshold (MNT) was defi ned as the lowest force of mechanical stimulation that produced a response. The MNT, in grams-force, was measured by determining the force applied to the coronary band until the stimulated limb was lifted off the ground. Positive responses were shoulder and withdrawal of the left foot.A simple withdrawal refl ex upon fi rst touch to the skin was not accepted as an end point. To minimize the variations between the measurements, fi ve evaluations were performed for each time, and the mean of the 3 closest values was then calculated. The horses had blinders on, so that they could not see the stimulus being applied. Behavioral alterations were reported descriptively.
The data were showed as mean±standard deviations. The software Sigma Stat -Windows was employed to analyze the data. The normal data were submitted to the Analysis of Variance (ANOVA) for repeated measurements, followed by the StudentNewman-Keuls (SNK) test for comparison of the intervals inside each treatment, and a one-way ANOVA followed by the SNK test was used for comparison among the treatments for each interval. For the data that did not have a normal distribution, the Kruskal Wallis' test was used followed by the SNK test. The results for the GI motility scores were analyzed by the Kruskal Wallis' test followed by SNK test. The level of signifi cance was taken at 5% (P<0.05).
RESULTS AND DISCUSSION
The detailed results for the HR, f R SAP, MAP and DAP are in study, GIORGI et al. (2007) observed the presence of tachycardia in 100% of the animals that received 5mg kg -1 of tramadol IV. There were no signifi cant differences in f R when comparing the doses of tramadol in Tr1 or Tr2. However, the Tr3 had a signifi cant increase in the f R at T5 (P=0.025) and remained above the basal values during the fi rst hour of evaluation (T10: P=0.032; T20: p=0.02; T60: P=0.04). An increase in f R was also described by DHANJAL et al. (2009) when injecting cumulative doses of tramadol intravenously in horses. The cause of the increase in f R remains unknown. However, it is believed that this increase may be associated with the secondary stimulation of the central nervous system.
One of the animals from the Tr1 showed a sudden increase in the f R (from 36 to 96 breaths per minute) at T60. This increase was associated with spasmodic contractions localized on the left fl ank region and in synchrony with the HR, suggesting synchronous diaphragmatic fl utter. As reported by MANSMANN et al. (1974) , the accentuated excitement may have contributed to the appearance of such alterations. There are no reports of diaphragmatic fl utter being triggered in horses by the administration of opioids in the literature. However, in human beings, the appearance of diaphragmatic myoclonus after the use of μ agonist opioids was described (LAUTERBACH et al., 1999) .
Blood pressures (SAP, MAP and DAP) increased 5 minutes after tramadol administration at the three doses studied. It is believed that the increase in arterial pressure may be directly associated with the stimulation of the sympathetic activity, due to the modulation and re-uptake of the monoamines triggered by the drug, especially of noradrenalin, as shown by SHIN et al. (2006) . However the values remained in the range considered normal for the horses. No statistical differences were found among the treatments (Table 1) .
Interestingly, even though no statistical differences among the treatments were noted (P>0.05), the alterations in the SAP, DAP, and MAP in the Tr1 did last longer than in the other treatments, mainly when compared to the 3mg kg -1 dose. This fi nding may be related to the dose-depressant hemodynamic effects triggered by the tramadol. Despite the fact that the mechanisms are not completely clear, it is known that such in vivo effects are caused by vascular, myocardial and nervous alterations. Whereas lower doses of tramadol can cause a transitory increase in arterial pressure with a concomitant increase in the noradrenalin concentrations, high doses of the drug can lead to vasodilatation through the production of nitric oxide and to effects on smooth muscle tissue, with a consequent decrease in arterial pressure (NAGAOKA et al., 2002) .
The gastrointestinal motility scores decreased signifi cantly in the Tr2 (T20) and persisted for 60 minutes [Score median baseline 11 (11/16); score median T20-T60: 8 (8/16)], (P<0.05).However, there was no statistical difference among tramadol treatments. The transitory decrease in the scores of GI motility was similar to the fi ndings described by DHANJAL et al. (2009) , who found that after the administration of 1.6mg kg -1 of tramadol, there was a signifi cant decrease in GI motility, persisting for 40 minutes. In accordance with WILDER-SMITH & BETTIGA (1997), the interference of tramadol with GI motility is related to the direct infl uence of the drug over the myenteric plexus by the central modulation via opioid or by monoaminergic mechanisms. The mild and transitory decrease in GI motility observe in this study suggests the advantage of the use of tramadol over other opioids such as morphine (BOSCAN et al., 2006) 
in horses.
Tramadol, regardless of the administered dose, did not cause any evident sedation as measured by a percentage difference in the head height.Using the same method, DHANJAL et al. (2009) also observed an absence of sedation, regardless of the dose of tramadol used.
The administered doses of tramadol did not change the MNT. No signifi cant differences were observed among the treatments or over time when compared to the baseline values of each treatment (Figure 1 ).The method used to evaluate the MNT was based on the absence of studies using mechanical stimuli to evaluate the effects of tramadol in horses. Considering the differences in excitability of the nociceptors, depending on the type of stimulus, it was hypothesized that results different from those already published in other studies would be observed. The maximum weight applied (1000gf) was determined considering the no evidence of tissue injury reported by KUKANIC et al. (2005) , using the similar technique in carpal pad dogs. The repeatability of the stimulus and the alteration in the mechanical threshold were some of our concerns and they are part of the limitations of the von Frey method. However, for the studies we based on papers written before that attest the feasibility of the technique. The choice of the coronary band based on the sensitivity of the region and easier evaluation of the withdrawal when pressure was exerted. Data regarding the mechanical threshold evaluation in palmar region in horses were 521 not reported. However, studies performed using von Frey fi laments on another body region were described as well tolerated and feasible in horses (RÉDUA et al., 2002; OLESKOVICZ et al., 2006) .
Similar results founded in this study were described by DHANJAL et al. (2009) when using thermal stimulation to evaluate the effects of tramadol in horses, with no alterations in the thermal threshold. According to the authors, such results would be related to the type of nociceptive fi ber involved and the stimulation of A-delta fi bers by the thermal method was most likely unaffected by the tramadol. A similar argument was applied to the present study. The mechanical stimulation by the von Frey method, when used on healthy tissues, would act preferably on type A fi bers (LE BARS et al., 2001) , and clinical doses of μ agonist opioids would primarily diminish the activity of type C fi bers (JURNA & HEINZ, 1979) . However, studies in dogs (KUKANICH et al., 2005; KUKANICH & PAPICH, 2011) have revealed the nociceptive effects of μ opioid agonists in animals with no tissue lesions by using mechanical stimuli, which would support the use of the von Frey method in this study.
The route of administration may also infl uence the absence of the effects of the tramadol over the MNT. As opposed to the presented results, other studies indicate that tramadol, when administered by epidural injection, may have a higher analgesic potential in horses (NATALINI & ROBINSON; 2000) . Using the electrical stimulation method, the authors observed long-duration analgesia after the administration of a 1mg kg -1 . Despite that fact, no pharmacokinetics studies compare the intravenous and the epidural methods of administration or associate such results with the clinical effects.
Behavioral alterations of different intensities occurred in the three treatments and were more evident during the administration of the drug and even after the fi rst 20 minutes. The alterations were more pronounced in the Tr3. At this treatment, the main fi ndings were lip droop (3/7), light contractions of the pectoral and lumbar muscles (3/7), general muscular contraction (2/7), drooling (1/7), ataxia (1/7) and stereotyped head movements. In the other treatments, the main alterations were the presence of lip droop (Tr2: 1/7; Tr3 3/7), light contractions of the pectoral muscles (2/7 in each treatment) and ataxia in only one (1/7) Tr2 horse.
The observed behavioral alterations agreed with the fi ndings of DHANJAL et al. (2009) , who described that IV tramadol administration in horses did not produce the classical effects of opioids, such as the act of digging and roaming in circles. However, muscle tremors were present in all the treatments, similar to what was described by other authors who used μ opioid agonists (GIORGI et al., 2007; DHANJAL et al., 2009; KNYCH et al., 2013) . It is believed that the decrease in the behavioral effects was due to the method of administration used in this study, the dilution of the drug and the increased time of infusion, proposed by SHILO et al. (2007) . The adverse effects resolved by 20 minutes post tramadol administration, probably associated a rapid decline in plasma tramadol concentrations as reported by KNYCH et al. (2013) for similarly doses evaluated in this study. It was concluded that the clinical alterations induced by the IV administration of tramadol in the doses of 1, 2 and 3mg kg -1 are light and transitory. However, in this model, tramadol did not have a mechanical antinociceptive effect at any of the evaluated doses.
